A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Transactions of the American Association of Genito-Urinary Surgeons

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 71777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Urologic Chronic Pelvic Pain Syndrome: A Scoping Review of Syndrome‐Specific Instruments

  2025cites this paper
• How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self‐administered patient questionnaire for male lower urinary tract symptoms

  2021cites this paper
• A protocol of systematic review and meta-analysis

  2021cites this paper
• Korean Version of the Patient Perception of Study Medication Questionnaire: Translation and Linguistic Validation

  2021cites this paper
• Questionnaires to Evaluate Lower Urinary Tract Symptoms in Men and Women

  2021cites this paper
• Success of Handmade Transobturator Slings Prepared From Conventional Polypropylene Mesh in the Treatment of Stress Urinary Incontinence in Women

  2020cites this paper
• Herbal medicine for benign prostatic hyperplasia

  2019cites this paper
• Flower Pollen Extract and its Effect on the Prostate Results of Treatment with Pollen Extract ( Cernilton ® N ) in Chronic Prostatitis and

  2017cites this paper
• Reliability and Validity Analysis of the Turkish Version of the Danish Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia

  2017cites this paper
• Flower Pollen Extract and its Effect on the Prostate Treatment of Outflow Tract Obstruction due To Benign Prostatic Hyperplasia with the Pollen Extract , Cernilton ® * A DOUBLE-BLIND , PLACEBO-CONTROLLED STUDY

  2017cites this paper
• 12 – Benign prostatic hyperplasia

  2016cites this paper
• Terminal dribbling in male patients with lower urinary tract symptoms: relationship with International Prostate Symptom Score and with intravesical prostatic protrusion

  2015cites this paper
• Acupuncture for benign prostatic hyperplasia: a systematic review protocol

  2015cites this paper
• Results of Treatment with Pollen Extract ( Cernilton ® ) in Prostatodynia and Chronic Prostatitis Results of Treatment with Pollen Extract ( Cernilton ® N ) in Chronic Prostatitis and

  2012cites this paper
• Drug Treatments for Lower Urinary Tract Symptoms Secondary to Bladder Outflow Obstruction

  2012cites this paper
• Quality-of-Life Assessment in Patients with Benign Prostatic Hyperplasia

  2012cites this paper
• Use of natural products to treat benign prostatic hyperplasia ( BPH ) and chronic non-bacterial prostatitis : emphasis on Cernitin ®

  2012cites this paper
• α1-Blockers vs 5α-Reductase Inhibitors in Benign Prostatic Hyperplasia

  2012cites this paper
• The evaluation of impact of BPH surgical treatment with the open prostatectomy and transurethral resection of the prostate methods on the quality of life.

  2011cites this paper
• Treatment satisfaction after 1 year high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.

  2010cites this paper
• Initial assessment of urinary and faecal incontinence in adult male and female patients

  2009cites this paper
• The psychometric validation of a US English satisfaction measure for patients with benign prostatic hyperplasia and lower urinary tract symptoms

  2009cites this paper
• Finasteride in the treatment of patients with benign prostatic hyperplasia: a review

  2009cites this paper
• Clinical and retrospective evaluation of eviprostat: A non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia

  2007cites this paper
• The International Prostate Symptom Score: Discrepancies between Self-administration and Physician-administration

  2007cites this paper
• The Difference in Mode of Administration of International Prostate Symptom Score (IPSS) in Patients with Lower Urinary Tract Symptoms

  2007cites this paper
• Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.

  2007cites this paper
• Impact of LUTS using bother index in DAN-PSS-1 questionnaire.

  2007cites this paper
• Doxazosin—An alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (Part one)

  2007cites this paper
• Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)

  2007cites this paper
• Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts.

  2006cites this paper
• Doxazosin—an alpha-1 receptor blocking agent in the long-term management of benign prostatic hyperplasia (BPH) (part two)

  2006cites this paper
• The Measurement of Nocturia and Its Impact on Quality of Sleep and Quality of Life in LUTS/BPH

  2006cites this paper
• LUTS/BPH in clinical practice: the importance of nocturia and quality of sleep

  2006cites this paper
• Current concepts in validity and reliability for psychometric instruments: theory and application.

  2006cites this paper
• Alfuzosin for symptomatic benign prostatic hyperplasia: long-term experience.

  2006cites this paper
• Assessment of lower urinary tract symptoms in women by a self-administered questionnaire: Test-retest reliability

  2005cites this paper
• URINARY AND FAECAL INCONTINENCE AMONG OLDER WOMEN AND MEN

  2005cites this paper
• Symptom scores: Mumbo jumbo or meaningful measures?

  2005cites this paper
• Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT Study)

  2005cites this paper
• A pilot study evaluating a new questionnaire for prostatic symptom scoring, the SPSS, and its sensitivity as constructed to objective measures of outflow obstruction

  2004cites this paper
• 5α-Reductase Inhibitors

  2004cites this paper
• International Prostate Symptom Score--IPSS-AUA as discriminat scale in 400 male patients with lower urinary tract symptoms (LUTS).

  2004cites this paper
• [Diagnosis of lower urinary tract obstruction in man. Guidelines of the German Society for Urologists].

  2004cites this paper
• Measuring quality of life in urogynaecology

  2004cites this paper
• Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review

  2004cites this paper
• Symptom severity and QOL scales for urinary incontinence.

  2004cites this paper
• Management of Benign Prostatic Hypertrophy

  2004influential citation
• Diagnostik der Obstruktion des unteren Harntraktes beim Mann

  2004cites this paper
• AUA guideline on the management of benign prostatic hyperplasia

  2003cites this paper
• Benign prostatic hyperplasia

  2003cites this paper
• CHANGE IN INTERNATIONAL PROSTATE SYMPTOM SCORE AFTER TRANSURETHRAL PROSTATECTOMY IN TAIWANESE MEN WITH BENIGN PROSTATE HYPERPLASIA: USE OF THESE CHANGES TO PREDICT THE OUTCOME

  2003cites this paper
• Use of the dysfunctional voiding symptom score to predict resolution of vesicoureteral reflux in children with voiding dysfunction.

  2003cites this paper
• Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.

  2003cites this paper
• Tamsulosin: an overview

  2002cites this paper
• The effect of finasteride in men with benign prostatic hyperplasia. 1992.

  2002cites this paper
• The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

  2002cites this paper
• A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index.

  2002cites this paper
• Treatment of benign prostatic hyperplasia: diagnosis and assessment

  2002cites this paper
• Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.

  2002cites this paper
• Validation of a Computer Version of the Patient-administered Danish Prostatic Symptom Score Questionnaire

  2001cites this paper
• The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part I: when statistics fail.

  2001cites this paper
• History of 7,093 Patients with Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia Treated with Alfuzosin in General Practice up to 3 Years

  2000cites this paper
• Correlation of Lower Urinary Tract Symptoms with Prostate Volume Parameters including Resistive Index and Presumed Circle Area Ratio in the Evaluation of Benign Prostatic Hyperplasia

  2000cites this paper
• The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children.

  2000cites this paper
• α-Blockers: An effective treatment for prostatitis?

  2000cites this paper
• Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature

  2000cites this paper
• 29 Quality-of-life: Statistical validation and analysis an example from a clinical trial

  2000cites this paper
• The measurement of symptoms, quality of life and sexual function

  2000cites this paper
• Effects of testosterone replacement in hypogonadal men.

  2000cites this paper
• Symptomatologie und Lebensqualität nach Transurethraler Resektion der Prostata (TUR-P)

  2000cites this paper
• Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder

  2000cites this paper
• Tamsulosin for the Treatment of Benign Prostatic Hypertrophy

  2000cites this paper
• Use of meta-analytic results to facilitate shared decision making.

  1999cites this paper
• Clinical features and management of benign prostatic hyperplasia.

  1999cites this paper
• Benign prostatic hyperplasia (the aging prostate).

  1999cites this paper
• Effect of testosterone treatment on bone mineral density in men over 65 years of age.

  1999cites this paper
• Health-related quality-of-life studies in urology: conceptual and methodological considerations

  1999cites this paper
• [Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice].

  1999cites this paper
• Research Paper: Use of Meta-analytic Results to Facilitate Shared Decision Making

  1999cites this paper
• Tamsulosin: 3-Year Long-Term Efficacy and Safety in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Analysis of a European, Multinational, Multicenter, Open-Label Study

  1999cites this paper
• Long‐term (4 year) efficacy and tolerability of doxazosin for the treatment of concurrent benign prostatic hyperplasia and hypertension

  1999cites this paper
• Veränderungen verschiedener Symptomenscores nach transurethraler Prostataresektion

  1999cites this paper
• Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction

  1999cites this paper
• Measuring the impact of nocturia on quality of life

  1999cites this paper
• Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group.

  1999cites this paper
• Impact of drug therapy on benign prostatic hyperplasia-specific quality of life.

  1999cites this paper
• Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire.

  1999cites this paper
• Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia.

  1998cites this paper
• Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group.

  1998cites this paper
• Clinical Uroselectivity: A 3-Year Follow-Up in General Practice

  1998cites this paper
• Natural history of prostatism: high American Urological Association Symptom scores among community-dwelling men and women with urinary incontinence.

  1998cites this paper
• The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia.

  1998cites this paper
• Outcome measures for research in treatment of adult males with symptoms of lower urinary tract dysfunction

  1998cites this paper
• Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study

  1998cites this paper
• Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice

  1998cites this paper
• Long-term implications of medical therapy on benign prostatic hyperplasia end points.

  1998cites this paper
• Significance of intermittency in men with lower urinary tract symptoms.

  1998cites this paper
• Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years

  1998cites this paper
• Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.

  1998cites this paper